A handful of providers are hijacking the arbitration process – and consumers are likely to foot the bill.
Articles on Health policy
Displaying 1 - 20 of 556 articles
A pensioner carve-out would mostly protect comfortable part-pensioners, while missing younger families who are struggling most.
Aboriginal and Torres Strait Islander men are not simply ‘hard to reach’, nor are they uninterested in their health.
Health systems are saving lives, but they have not expanded rehabilitation services at the same pace.
Mental health should be treated as part of education quality, learner safety and inclusion.
Donations of A$7.7 million over a decade have been disclosed. But that’s not the full amount, a new study shows.
Sexual enhancement supplements often contain unlisted prescription drugs that pose serious health risks.
We’re seeing what happens when consumer demand collides with commercial interests for drugs including GLP-1s, psychedelics and testosterone. It’s a huge shift.
US-funded research into the health of people abroad has large health and economic benefits for Americans.
People at the highest risk of severe COVID will still be eligible for free vaccines. Others may have to pay.
Leave for the non-birthing parent after a new baby arrives gives the family an opportunity to bond.
South Korea’s unusually rapid transition to a super-aged society means it has had little time to find solutions for pension funding and healthcare for the elderly.
Portugal’s remarkable public health strides after changing its approach to drugs may not be replicable in other countries absent broader systemic reforms.
Government critics say changes to health insurance rebates will strain the public health system. But the evidence shows the impact might not be what you think.
Monoclonal antibody drugs like Keytruda attack cancer cells in a different way to chemotherapy drugs.
Measles is making a comeback around the world. In places with low vaccination rates, a few cases can quickly become an epidemic.
A recent case involving a patient harmed in an overcrowded ED highlights the need for a fresh look at how NZ investigates clinical errors.
Large datasets can be useful research tools, but current government efforts to gather medical records depend on policy and technology that falls short of protecting people’s privacy.
The government wants to cut $37.8 billion from the NDIS over 4 years. Much of this will come from tightening access to the scheme and reducing participants’ plans.
Trump’s latest executive order is set to lead to delayed vaccinations, falling coverage and a resurgence of diseases once brought under control.
Top contributors
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Program Director, Health and Aged Care, Grattan Institute
-
Professor of Health Economics, The University of Melbourne
-
Professor of Health Economics and Director, Centre for Health Economics, Monash Business School, Monash University
-
Professor, Public Service Research, UNSW
-
Jim Gillespie is a Friend of The Conversation.
Associate Professor in Health Policy, Leeder Centre for Health Policy, Economics and Data & Sydney School of Public Health, University of Sydney
-
Professor and Director, Macquarie University Centre for the Health Economy, Macquarie University
-
Reader in Health Economics, Centre for Health Economics, University of York
-
Adjunct Associate Professor, Menzies Centre for Health Policy and Economics, University of Sydney
-
Emeritus Professor, Menzies Centre for Health Policy, University of Sydney
-
Associate Professor, Brain and Mind Centre, University of Sydney; University of Canberra
-
Emeritus Professor of Public Health, La Trobe University
-
Professor of Health Economics, University of Technology Sydney
-
Lecturer, Public Sector Finance, University of Canberra
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney